Our interdisciplinary team of scientists collaborates to develop nanovaccines and nanotherapeutics
No needles, no boosters: extended-release nanovaccines can be delivered by nasal inhaler rather than injection
Nanovaccines don't need refrigeration (polio campaign worker in India carrying styrofoam cooler for vaccine)
Nanotherapeutics use lower dosages than systemic drugs, allowing life-saving drugs to be used for young children
Nanovaccines can prevent respiratory infections such as influenza
Nanoparticles can deliver therapeutic agents across the blood-brain barrier to treat neural disorders such as Alzheimer's, Parkinson's, and traumatic brain injury
Nanovaccines can prevent tropical diseases such as malaria and filariasis
For cancers, we are researching tumor-specific targets for nanotherapeutics
Veterinary nanovaccines delivered in feed can prevent viral diseases in farmed shrimp
Nanoparticles average only 300 nanometers in diameter, 1000 times smaller than the period at the end of a sentence.
Our nanovaccine consortium is a diverse, interdisciplinary team (group photo at our May 2015 annual meeting)